Literature DB >> 21107741

Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.

Nehmat Houssami1, Daniela Ambrogetti, M Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P Mamounas, Stefano Ciatto.   

Abstract

BACKGROUND: Core needle biopsy (CNB) diagnoses of ductal carcinoma-in-situ (DCIS) may represent understaged invasive breast cancer (IBC). We aimed to develop a model that helps identify preoperatively women with IBC after a CNB diagnosis of DCIS.
METHODS: Retrospective study of all women with DCIS on vacuum-assisted CNB of microcalcifications (1999-2008), with prospective classification of imaging variables independently by two radiologists. Variables included lesion size and level of suspicion on imaging, morphology and distribution of microcalcifications, DCIS nuclear grade on CNB, number of cores, and age. Multivariate logistic regression models of the probability of IBC were developed; the accuracy of these models was examined for each radiologist.
RESULTS: Excision histology showed IBC in 77 (17.4%) of 442 subjects with DCIS on CNB. Lesion size on imaging yielded the best model fit and highest accuracy, and had the highest agreement between radiologists. Addition of grade to a model which included size improved model fit (P < 0.0001). However, model fit and accuracy were not improved by inclusion of any other variables. A model based on size and grade had similar areas under the receiver operating characteristic curve (accuracy of 74%) for each radiologist. Modeled sensitivity, specificity, and predictive values for different combinations of size and grade thresholds are reported. If the imaging lesion is >50 mm and the CNB grade is high, the model's positive predictive value is ≥50%.
CONCLUSIONS: A model based on imaging size of microcalcifications and CNB nuclear grade can identify women at high risk of having IBC with moderate accuracy and may be used to guide informed preoperative discussion in women with newly diagnosed DCIS on CNB.

Entities:  

Mesh:

Year:  2010        PMID: 21107741     DOI: 10.1245/s10434-010-1438-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade.

Authors:  Geunwon Kim; Peter G Mikhael; Tawakalitu O Oseni; Manisha Bahl
Journal:  Eur Radiol       Date:  2020-06-26       Impact factor: 5.315

2.  Prediction of invasive breast cancer using shear-wave elastography in patients with biopsy-confirmed ductal carcinoma in situ.

Authors:  Jae Seok Bae; Jung Min Chang; Su Hyun Lee; Sung Ui Shin; Woo Kyung Moon
Journal:  Eur Radiol       Date:  2016-04-16       Impact factor: 5.315

3.  Randomized controlled trial of stereotactic 11-G vacuum-assisted core biopsy for the diagnosis and management of mammographic microcalcification.

Authors:  Sara M Bundred; Anthony J Maxwell; Julie Morris; Yit Y Lim; Md Janick Harake; Sigrid Whiteside; Nigel J Bundred
Journal:  Br J Radiol       Date:  2015-12-14       Impact factor: 3.039

Review 4.  Status quo and development trend of breast biopsy technology.

Authors:  Yan-Jun Zhang; Lichun Wei; Jie Li; Yi-Qiong Zheng; Xi-Ru Li
Journal:  Gland Surg       Date:  2013-02

5.  Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?

Authors:  Tawakalitu O Oseni; Barbara L Smith; Constance D Lehman; Charmi A Vijapura; Niveditha Pinnamaneni; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-05-16       Impact factor: 5.344

6.  The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.

Authors:  Christine Tunon-de-Lara; Marie Pierre Chauvet; Marie Christine Baranzelli; Marc Baron; Jean Piquenot; Guillaume Le-Bouédec; Fréderique Penault-Llorca; Jean-Rémi Garbay; Jérôme Blanchot; Joëlle Mollard; Véronique Maisongrosse; Simone Mathoulin-Pélissier; Gaëtan MacGrogan
Journal:  Ann Surg Oncol       Date:  2015-03-17       Impact factor: 5.344

7.  The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer.

Authors:  Tao Sun; Hanwen Zhang; Wei Gao; Qifeng Yang
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

8.  Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy.

Authors:  Suzanne C E Diepstraten; Stephanie M W Y van de Ven; Ruud M Pijnappel; Petra H M Peeters; Maurice A A J van den Bosch; Helena M Verkooijen; Sjoerd G Elias
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

9.  The predictive value of calcification for the grading of ductal carcinoma in situ in Chinese patients.

Authors:  Jianchun Kong; Xiaomin Liu; Xiaodan Zhang; Yu Zou
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

10.  Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.

Authors:  Jing Si; Rong Guo; Naisi Huang; Bingqiu Xiu; Qi Zhang; Weiru Chi; Jiong Wu
Journal:  Cancer Med       Date:  2019-10-29       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.